Technological innovations and breakthrough pathways in syphilis diagnosis: addressing global resurgence and the journey toward elimination

, spanning from molecular precision to decentralized point-of-care (POC) accessibility. This review synthesizes the paradigm shift from traditional darkfield microscopy (DFM) toward advanced nucleic acid amplification tests (NAATs). By evaluating innovations such as CRISPR-based assays and transcription-mediated amplification (TMA), we highlight their capacity to bridge the diagnostic 'window period' where traditional serology often fails. Furthermore, the review evaluates the clinical adaptability of automated reverse-sequence algorithms and the utilization of signal-to-cutoff (S/Co) ratios to optimize high-throughput laboratory workflows. Significant attention is given to breakthroughs in biosensing-such as silk cocoon membrane-integrated platforms-and the role of novel biomarkers like IgA and proteomic arrays in differentiating active infection from historical exposure. The significance of this review lies in its comprehensive mapping of "breakthrough pathways" that address diagnostic bottlenecks in complex manifestations like neurosyphilis and neonatal cases. Evidence suggests that while these technological breakthroughs possess transformative potential, their global scalability remains constrained by a dual challenge: the lack of standardized commercial platforms and the diagnostic ambiguity posed by the 'serofast' state. Consequently, the integration of these innovations into routine practice requires moving beyond isolated tools toward a cohesive, multimodal diagnostic framework Future perspectives emphasize the integration of smartphone-based AI diagnostics and the necessity of aligning technological advancements with biomedical prevention strategies, such as DoxyPEP and multi-epitope vaccine development. Ultimately, establishing a multi-modal diagnostic ecosystem that prioritizes health equity and real-time surveillance is essential for dismantling the systemic barriers to global syphilis elimination.